MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacadv.2025.102363

Медицинская библиотека · JACC. Advances · 2025

Enhancing Prediction of Cancer Therapy-Related Cardiomyopathy From Surveillance Echocardiograms: A Children's Oncology Group Study.

Leger Kasey J, Stratton Kayla L, Sachdeva Ritu, Armenian Saro H, Bhat Aarti H, Boyle Patrick M, Edwards Lindsay A, Meacham Lillian R, Narasimhan Shanti, Nathan Paul C, Sadak Karim T, Sharma Surbhi, Border William L, Leisenring Wendy M, Chow Eric J

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Early echocardiographic indicators of cardiac remodeling may enhance cardiomyopathy risk prediction in childhood cancer survivors (CCS).

OBJECTIVES

The objective of the study was to assess whether influential echocardiographic measures can be combined to develop a robust cardiomyopathy risk prediction model in CCS.

METHODS

Multicenter retrospective study of ≥1-year CCS with digitally archived surveillance echocardiograms, enrolled cardiomyopathy cases (left ventricular [LV] fractional shortening ≤28% or LV ejection fraction ≤50% on ≥2 occasions) and noncases (≥5-year CCS who maintained fractional shortening ≥ 30% and ejection fraction ≥55% without initiation of cardiac medications). Echocardiograms were centrally quantitated in a blinded fashion. Least absolute shrinkage and selection operator regression identified the most influential 2-year predictors of cardiomyopathy among 27 echocardiographic parameters. Logistic regression was used to generate ORs with 95% CIs. Estimates were applied to the training and test data sets to generate area under the receiver operating characteristic curves (AUC).

RESULTS

Data from 146 CCS (52 cases; 94 noncases) with a median follow-up of 9.3 years post-cancer diagnosis and a total of 281 echocardiograms were included. A set of 7 echocardiographic measures were identified as the most influential predictors, with AUC of 0.82 (95% CI: 0.74-0.89) and 0.85 (95% CI: 0.74-0.95) in the training and test data sets, respectively. LV end-systolic dimension (ORmm: 1.2; 95% CI: 1.1-1.4), apical 4-chamber longitudinal strain (OR%: 1.2; 95% CI: 1.0-1.3), and septal A' velocity (ORcm/s: 1.3; 95% CI: 1.1-1.6) were strongly predictive of cardiomyopathy. AUCs were similar if cancer treatment exposures were included.

CONCLUSIONS

Early abnormalities in echocardiographic parameters of structure and function predict subsequent cardiomyopathy in CCS and can identify high-risk survivors who warrant early intervention.

Для цитирования: Leger Kasey J, Stratton Kayla L, Sachdeva Ritu, Armenian Saro H, Bhat Aarti H, Boyle Patrick M, Edwards Lindsay A, Meacham Lillian R, Narasimhan Shanti, Nathan Paul C, Sadak Karim T, Sharma Surbhi, Border William L, Leisenring Wendy M, Chow Eric J. Enhancing Prediction of Cancer Therapy-Related Cardiomyopathy From Surveillance Echocardiograms: A Children's Oncology Group Study.. JACC. Advances. 2025. DOI: 10.1016/j.jacadv.2025.102363.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.